Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD)
BDMD moved a median of -0.29% 30 minutes after news, and -0.62% by the close. How BDMD actually reacts to news — the realized, point-in-time move the market made, measured across 107 labeled events over the last three years with zero look-ahead.
BDMD’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 100 |
| 30-min | -0.29% | 49% | 105 |
| 60-min | +0.07% | 51% | 106 |
| to close | -0.62% | 43% | 106 |
| Middle 50% of BDMD reactions | -2.44% to +3.39% |
|---|---|
| Median reaction (30-min) | -0.29% |
| Measured reactions | 107 |
Half of all Baird Medical Investment Holdings Ltd - Ordinary Share news events land between -2.44% and +3.39% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BDMD moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BDMD's baseline. Nothing else.
Recent BDMD events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED | Press release | GlobeNewswire | -0.10% | +7.30% | |
| Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System | Press release | GlobeNewswire | +2.71% | +52.47% | |
| Form 6-K Baird Medical Investment For: Nov 05 | SEC filing · Form 6-K | SEC EDGAR | +2.71% | +52.47% | |
| Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | Press release | GlobeNewswire | +2.71% | +52.47% | |
| Baird Medical Issues Statement Regarding Recent Share Price Volatility | Press release | GlobeNewswire | +2.71% | +52.47% | |
| Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China | Press release | GlobeNewswire | -32.31% | -29.05% | |
| Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology | Press release | GlobeNewswire | +0.00% | -23.37% | |
| Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026 | Press release | GlobeNewswire | +0.64% | -0.46% | |
| Form 6-K Baird Medical Investment For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.70% | +2.63% | |
| Form 6-K Baird Medical Investment For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | +1.23% | -3.34% | |
| Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology | Press release | GlobeNewswire | +3.50% | -4.50% | |
| Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026 | Press release | GlobeNewswire | -1.74% | +1.74% | |
| Form 6-K Baird Medical Investment For: Sep 03 | SEC filing · Form 6-K | SEC EDGAR | -1.74% | +1.74% | |
| Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan | Press release | GlobeNewswire | +4.54% | +5.46% | |
| Form EFFECT Baird Medical Investment | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -3.54% | |
| Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally | Press release | GlobeNewswire | -0.83% | — | |
| Form F-3/A Baird Medical Investment | SEC filing · Form F-3 | SEC EDGAR | +7.96% | +7.96% | |
| Form POS AM Baird Medical Investment | SEC filing · Form POS | SEC EDGAR | +7.96% | +7.96% | |
| Form 20-F/A Baird Medical Investment For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -1.83% | -1.83% | |
| Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina | Press release | PR Newswire | +5.66% | +7.55% | |
| Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion | Press release | PR Newswire | +0.01% | +1.59% | |
| Form F-3 Baird Medical Investment | SEC filing · Form F-3 | SEC EDGAR | -3.07% | +0.00% | |
| Form POS AM Baird Medical Investment | SEC filing · Form POS | SEC EDGAR | -3.07% | +0.00% | |
| Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update | Press release | PR Newswire | -4.16% | +1.79% | |
| Form 20-F Baird Medical Investment For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +1.10% | -3.85% | |
| Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia | Press release | PR Newswire | -5.06% | -9.80% | |
| Baird Medical Expands Global Reach with Regulatory Clearance in Argentina | Press release | PR Newswire | -1.16% | -14.34% | |
| Form S-8 Baird Medical Investment | SEC filing · Form S-8 | SEC EDGAR | -2.79% | -4.18% | |
| Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026 | Press release | PR Newswire | +1.50% | -4.33% | |
| Baird Medical Accelerates Global Registration of AI-Driven Surgical Software | Press release | PR Newswire | +7.36% | +33.33% | |
| Baird Medical Accelerates U.S. Expansion at NASOIE 2026 | Press release | PR Newswire | +7.77% | -9.94% | |
| Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology | Press release | PR Newswire | +0.54% | +26.20% | |
| Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences | Press release | PR Newswire | +10.91% | +6.16% | |
| Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital | Press release | PR Newswire | -2.10% | -11.63% | |
| Form 6-K Baird Medical Investment For: Feb 10 | SEC filing · Form 6-K | SEC EDGAR | -7.05% | -14.27% | |
| Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan | Press release | PR Newswire | -2.58% | +4.12% | |
| Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass | Press release | PR Newswire | -1.89% | +2.83% | |
| Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital | Press release | PR Newswire | -3.21% | -5.50% | |
| Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference | Press release | PR Newswire | -1.62% | -8.06% | |
| Form EFFECT Baird Medical Investment | SEC filing · Form EFFECT | SEC EDGAR | -3.54% | -9.45% | |
| Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam | Press release | PR Newswire | -0.78% | +4.69% | |
| Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D | Press release | PR Newswire | +3.00% | +3.70% | |
| Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment Capabilities for Leading Arizona Surgeon | Press release | PR Newswire | +0.00% | -3.73% | |
| Form 6-K Baird Medical Investment For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -3.73% | |
| Form F-1/A Baird Medical Investment | SEC filing · Form F-1 | SEC EDGAR | +0.00% | -3.73% | |
| Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | Press release | PR Newswire | +2.96% | +11.11% | |
| Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation | Press release | PR Newswire | -2.06% | -11.19% | |
| Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice | Press release | PR Newswire | -0.70% | +0.70% | |
| Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh | Press release | PR Newswire | -1.31% | -6.54% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BDMD section they belong to.
Where else BDMD is measured.
BDMD earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Baird Medical Investment Holdings Ltd - Ordinary Share's median reaction calculated?
Every labeled BDMD news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 107 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of BDMD's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BDMD's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.